SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-070706
Filing Date
2024-06-07
Accepted
2024-06-07 16:30:17
Documents
1
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5405
  Complete submission text file 0000950170-24-070706.txt   6924
Mailing Address C/O SYROS PHARMACEUTICALS, INC. 620 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Simonian Nancy A (Reporting) CIK: 0001359574 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37813 | Film No.: 241030018

Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Issuer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)